Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)
0.7400
0.00 (0.00%)
Feb 13, 2026, 3:49 PM HKT
HKG:3737 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 20.56 | 95.21 | 162.78 | 106.39 | 52.13 | 138.53 |
Depreciation & Amortization | 104.49 | 108.13 | 99.48 | 93.58 | 82.46 | 99.75 |
Other Amortization | 3.29 | 3.29 | 2.6 | 2.8 | 2.59 | - |
Loss (Gain) From Sale of Assets | 1.36 | 1.2 | -0.43 | -0.69 | -0.11 | 0.22 |
Loss (Gain) From Sale of Investments | 3.48 | 3.9 | -3.61 | -2.43 | 40.44 | -7.51 |
Stock-Based Compensation | - | - | - | - | - | 1.12 |
Provision & Write-off of Bad Debts | 3.48 | 4.1 | 0.47 | -0.16 | 0.44 | 0.39 |
Other Operating Activities | -8.87 | -1.16 | -15.37 | -3.04 | -27.84 | -9.04 |
Change in Accounts Receivable | 12.14 | -119.74 | -18.22 | -13.59 | 10.03 | -52.99 |
Change in Inventory | 32.26 | -22.4 | -10.65 | -59.79 | -21.03 | -48.2 |
Change in Accounts Payable | 20.21 | 104.99 | 1.19 | 68.95 | 10.39 | 6.14 |
Change in Unearned Revenue | 3.22 | 4.88 | 8.67 | 10.53 | 10.57 | 9.51 |
Change in Other Net Operating Assets | 1.81 | -0.92 | -125.39 | 82.03 | 18.31 | -44.74 |
Operating Cash Flow | 197.4 | 181.48 | 101.5 | 284.57 | 178.38 | 93.18 |
Operating Cash Flow Growth | 17.00% | 78.79% | -64.33% | 59.53% | 91.44% | -44.48% |
Capital Expenditures | -63.79 | -140.76 | -169.18 | -88.41 | -185.85 | -113.99 |
Sale of Property, Plant & Equipment | 2.97 | 3.82 | 17.1 | 21.83 | 2.53 | 9.22 |
Sale (Purchase) of Intangibles | -10.59 | -1.1 | -2.25 | -0.74 | -2.01 | -3.84 |
Investment in Securities | -20.4 | 3.24 | -55.45 | 70.95 | 22.7 | -143.39 |
Other Investing Activities | 4.53 | 14.73 | 7.02 | 9.76 | 26.66 | 1.58 |
Investing Cash Flow | -87.27 | -120.06 | -202.76 | 13.38 | -135.98 | -250.42 |
Short-Term Debt Issued | - | - | - | - | 123.87 | 78.92 |
Long-Term Debt Issued | - | 52.36 | 49.67 | 10.5 | - | - |
Total Debt Issued | 39.2 | 52.36 | 49.67 | 10.5 | 123.87 | 78.92 |
Short-Term Debt Repaid | - | - | - | - | -145.54 | -31.35 |
Long-Term Debt Repaid | - | -83.65 | -88.63 | -78.67 | -45.41 | -38.26 |
Total Debt Repaid | -125.89 | -83.65 | -88.63 | -78.67 | -190.96 | -69.62 |
Net Debt Issued (Repaid) | -86.69 | -31.29 | -38.96 | -68.16 | -67.09 | 9.3 |
Issuance of Common Stock | - | - | - | - | 30.04 | - |
Repurchase of Common Stock | -1.7 | -3.57 | - | - | -4.38 | -12.32 |
Common Dividends Paid | -38.55 | -23.14 | -116.15 | - | - | -48.97 |
Other Financing Activities | - | -0.73 | 0.49 | 0.02 | 0.6 | 1.5 |
Financing Cash Flow | -126.94 | -58.74 | -154.62 | -68.14 | -40.83 | -71.93 |
Foreign Exchange Rate Adjustments | -0.59 | 0.05 | -0.77 | -2.18 | 0.78 | -0.13 |
Net Cash Flow | -17.4 | 2.74 | -256.64 | 227.63 | 2.35 | -229.3 |
Free Cash Flow | 133.61 | 40.72 | -67.68 | 196.17 | -7.47 | -20.81 |
Free Cash Flow Margin | 6.66% | 1.84% | -3.30% | 10.74% | -0.43% | -1.30% |
Free Cash Flow Per Share | 0.16 | 0.05 | -0.08 | 0.23 | -0.01 | -0.03 |
Cash Interest Paid | 1.72 | 2.63 | 2.61 | 1.92 | 2.67 | 1.39 |
Cash Income Tax Paid | 26.54 | 44 | 42.54 | 17.37 | 23.88 | 21.98 |
Levered Free Cash Flow | -6.31 | 27.57 | -103.76 | 245.16 | -49.32 | -42.33 |
Unlevered Free Cash Flow | -2.83 | 31.94 | -98.84 | 249.26 | -44.89 | -39.07 |
Change in Working Capital | 69.63 | -33.2 | -144.41 | 88.13 | 28.26 | -130.28 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.